M

MPM Capital

46 employees

MPM Capital is a biotechnology investment firm that invests in companies to develop therapeutic technologies in oncology.

Investor insights

Sectors invested in

Biotechnology149
Health Care120
Therapeutics70
Pharmaceutical59
Medical52
Biopharma26
Medical Device24
Oncology17
Health Diagnostics16
Life Science16
Genetics14
Clinical Trials12
Manufacturing11
biotechnology8
Diabetes5
Ovation Prime5
Customized Seal5
Endovascular Aortic Repair5
Infectious Diseases4
Monoclonal Antibodies4

Funding rounds participated in

$16M sweet spot round size

Most of their 261 investments are in rounds between $18M and $50M

Investor type

Private Equity Firm
Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Cancer Therapy
Biotechnology
Health Care
Venture Creation
Biotech
Funding companies to make a difference
Life Science
Venture Capital
Disease Treatment
Investment
Pharmaceuticals

Date founded

1996

Investments made

R

ReCode Therapeutics raised $50M on September 19, 2023

Investors: Sanofi Ventures, OrbiMed Advisors, Solasta Ventures, Vida Ventures, LLC, Leaps by Bayer, Osage University Partners (OUP) and MPM Capital

A

Arialys Therapeutics, Inc. raised $58M on September 12, 2023

Investors: Avalon BioVentures, Catalys Pacific and MPM Capital

C

Crossbow Therapeutics, Inc raised $80M on July 11, 2023

Investors: Polaris Partners and MPM Capital

R

ReNAgade Therapeutics raised $300M on May 23, 2023

Investors: MPM Capital

N

NextPoint Therapeutics, Inc. raised $80M on January 10, 2023

Investors: Sanofi Ventures, Catalio Capital Management, Sixty Degree Capital, Leaps by Bayer, The Invus Group and MPM Capital

P

Photys Therapeutics raised $75M on September 8, 2022

Investors: Heritage Medical Systems, Omega Funds, Longwood Fund, 8VC and MPM Capital

A

Aktis Oncology raised $84M on August 25, 2022

Investors: Octagon Capital Advisors, NS Investment, Pappas Capital, TCG X, Merck Group, Vida Ventures, LLC and MPM Capital

O

Orna Therapeutics raised $221M on August 16, 2022

Investors: Merck Group and MPM Capital

C

CODA Biotherapeutics raised $28M on December 2, 2021

Investors: Pacira Pharmaceuticals, Versant Ventures and MPM Capital

R

ReCode Therapeutics raised $210M on October 21, 2021

Investors: Sanofi Ventures, NS Investment, -, OrbiMed Advisors, Vida Ventures, LLC, Tekla Capital Management, Osage University Partners (OUP) and MPM Capital

FAQ